MORRISTOWN, NJ – November 10, 2015 – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will host investor meetings at two upcoming conferences:
- Brean Capital 2015 Life Sciences Summit on November 16, 2015 at the Millennium Broadway Hotel in New York City.
- Jefferies Autumn 2015 Global Healthcare Conference, November 18-19, 2015 at The May Fair Hotel in London.
About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
To learn more about Pernix Therapeutics, visit www.pernixtx.com.
Sanjay Patel, (800) 793-2145 ext. 1009
Chief Financial Officer
Lisa Wilson, (212) 452-2793
In-Site Communications, Inc.
Marianne Lambertson, (800) 793-2145 ext. 1012
Vice President, Strategic Development